文献速递临床试验与 GCP

芦荟、洋甘菊和百里香 cosmetic 乳膏预防和治疗乳腺癌患者放疗所致轻度皮炎的疗效:一项对照临床试验(Alantel 试验)

Efficacy of an aloe vera, chamomile, and thyme cosmetic cream for the prophylaxis and treatment of mild dermatitis induced by radiation therapy in breast cancer patients: a controlled clinical trial (Alantel Trials).
PubMed 文献 · Trials · 2024-01-25

该试验为前瞻性、三盲、多中心、对照临床试验,计划纳入88例接受放疗的乳腺癌患者,随机分为Alantel乳膏组和保湿乳膏对照组,主要评价轻度放射性皮炎发生率。原文报告研究因COVID-19疫情延迟启动,并指出招募受试者所需时间为主要局限之一。

要点

  • Alantel乳膏含高浓度天然成分,拟用于预防及早期治疗放射性皮炎。
  • 试验计划招募88例乳腺癌放疗患者,每组44例,随机分配至Alantel组或保湿乳膏组。
  • 主要研究变量为轻度放射性皮炎发生率,采用意向性分析。

核心结论

  • 原文预期通过该临床试验验证基于高浓度天然成分的Alantel乳膏在预防和治疗乳腺癌患者放射性皮炎方面优于保湿乳膏。

研究设计与样本

  • 实验性、前瞻性、三盲、多中心、对照临床试验,设两个平行组。
  • 计划招募88例接受放疗的乳腺癌患者,每组44例,随机分配至Alantel组或保湿乳膏对照组。
  • 患者接受放疗15天,放疗结束后由初级保健医生随访四次,至放疗完成后1周。

关键数值与推荐

  • 主要研究变量为轻度放射性皮炎发生率。
  • 采用意向性分析,应用独立均值和比例的对比检验。
  • 进行双变量和多变量分析以核查治疗效果,并调整预测性社会人口学和临床变量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • COVID-19疫情影响了研究的启动时间,导致延迟。
  • 招募计划样本中的患者所需时间为该研究的主要局限之一,因选择标准严格。
  • 尽管研究为多中心,招募将通过单一放疗肿瘤服务协调。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dermatitis is a skin condition caused by multiple causes, including radiotherapy treatment. Pharmacological treatments can become chronic and are not exempt from side effects. The latest recommendations of the American Academy of Dermatology establish the use of natural, nourishing, and moisturizing cosmetic products as prevention and the first therapeutic step for dermatitis. Alantel® is a cream developed to reduce redness and irritation, promote the local immune system, combat immunosenescence, and promote the healing of epidermal lesions. The objective was to evaluate the effect of a cream (Alantel) based on natural products at high concentrations for the preventive and curative treatment (at early stages) of radiation-induced dermatitis in patients with breast cancer. METHODS: Our protocol is an experimental, prospective, triple-blind, multicenter, controlled clinical trial with two parallel arms. The experimental group will be treated with Alantel, while the control group will receive another moisturizing cream. Radiotherapy oncology professionals will recruit a total of 88 patients (44 per comparison group) with breast cancer who will receive radiotherapy oncology treatment for 15 days, and they will be randomly allocated to the experimental or control group. Selected patients will be followed up for four visits by primary care physicians for up to 1 week after completion of radiotherapy. The main study variable will be the incidence rate of mild post-radiation dermatitis. An intention-to-treat analysis will be performed, applying a comparison test for independent means and proportions. A bivariate and multivariate analysis will also be developed to check the treatment effect, adjusting for predictive sociodemographic and clinical variables. DISCUSSION: By carrying out this clinical trial, it is expected to verify that Alantel cream, based on natural products at high concentrations, has advantages over a moisturizing cream for the preventive and curative treatment of RD in patients with breast cancer. The COVID-19 pandemic has been influenced by delaying the start of the study. One of the main limitations of this study will be the time required to recruit the patients from the planned sample, given that the selection criteria are restrictive and, although the study is multicenter, recruitment will be coordinated through a single service on radiotherapy oncology. TRIAL REGISTRATION: ClinicalTrials.gov NCT04116151 . Registered on 4 October 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jimenez-Garcia C, Perula-de Torres LA, Villegas-Becerril E, et al. Efficacy of an aloe vera, chamomile, and thyme cosmetic cream for the prophylaxis and treatment of mild dermatitis induced by radiation therapy in breast cancer patients: a controlled clinical trial (Alantel Trials). Trials. 2024. PMID: 38273379. doi:10.1186/s13063-024-07901-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。